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Efficient and reliable sample delivery has remained one of the bottlenecks for
serial crystallography experiments. Compared with other methods, fixed-target
sample delivery offers the advantage of significantly reduced sample consump-
tion and shorter data collection times owing to higher hit rates. Here, a new
method of on-chip crystallization is reported which allows the efficient and
reproducible growth of large numbers of protein crystals directly on micro-
patterned silicon chips for in-situ serial crystallography experiments. Crystals are
grown by sitting-drop vapor diffusion and previously established crystallization
conditions can be directly applied. By reducing the number of crystal-handling
steps, the method is particularly well suited for sensitive crystal systems.
Excessive mother liquor can be efficiently removed from the crystals by blotting,
and no sealing of the fixed-target sample holders is required to prevent the
crystals from dehydrating. As a consequence, ‘naked’ crystals are obtained on
the chip, resulting in very low background scattering levels and making the
crystals highly accessible for external manipulation such as the application of
ligand solutions. Serial diffraction experiments carried out at cryogenic
temperatures at a synchrotron and at room temperature at an X-ray free-
electron laser yielded high-quality X-ray structures of the human membrane
protein aquaporin 2 and two new ligand-bound structures of thermolysin and
the human kinase DRAK2. The results highlight the applicability of the method
for future high-throughput on-chip screening of pharmaceutical compounds.
1. Introduction
Serial crystallography (SX) at X-ray free-electron lasers
(XFELs) and, more recently, at the latest low-emittance
synchrotron sources has changed the way that data can be
collected for X-ray structure determination (Chapman et al.,
2011). In contrast to conventional crystallography, in which
structure determination is typically based on diffraction data
collection from one or a very few larger crystals that are
rotated in the X-ray beam, SX is based on recording still
images from several tens to hundreds of thousands of
microcrystals (Stellato et al., 2014; Boutet et al., 2012; Meents
et al., 2017).
The reliable and efficient delivery of microcrystals into
the X-ray beam has remained a bottleneck for SX. Several
different sample-delivery approaches have been reported,
including liquid jet streaming from gas dynamic virtual nozzles
(GDVNs; DePonte et al., 2008; Weierstall, 2014), lipidic cubic
phase injectors (Weierstall et al., 2014; Fromme et al., 2015;
Nogly et al., 2016), different tape drives (Roessler et al., 2013;
Beyerlein et al., 2017) and solid supports (Zarrine-Afsar et al.,
2012; Hunter et al., 2014; Roedig et al., 2015, 2016; Murray et al.,
2015). Among these, liquid jets have been the most common
method for sample delivery to date. Despite being subjected to
constant optimization (Oberthuer et al., 2017), structure
determination using liquid jets still requires large amounts of
sample, making them inapplicable for more challenging
systems, which are often available in small quantities only.
A more promising approach in terms of sample consump-
tion and efficient use of the sample available is the use of solid
supports or so-called fixed targets. Here, the microcrystals are
located at predefined positions on the substrate and are then
raster-scanned through the X-ray beam. This allows efficient
high-quality data collection with high hit fractions and low
background scattering levels both at XFELs and synchrotrons
(Roedig et al., 2015, 2017), where the scanning speed is well
matched to the measurement rates, which are dictated by the
detector frame rates or source repetition rates.
A further challenge for many SX experiments, in particular
for ligand-binding studies and also time-resolved experiments,
is the need for high-quality microcrystals (Kupitz et al., 2014).
The use of crystals with sizes of only a few micrometres allows
the efficient diffusion of a ligand or a substrate into the crystal
without substantial deterioration of the crystal quality. Since
the diffusion times are in the low-millisecond range (Schmidt
& Saldin, 2014), structural changes involved in ligand binding
or enzyme reactions can be studied on at least similar time
scales (Stagno et al., 2017; Kupitz et al., 2017; Beyerlein et al.,
2017). For time-resolved pump–probe experiments using laser
excitation, microcrystals can be excited more homogeneously
over the entire crystal volume compared with larger crystals
and hence can provide better data (Pande et al., 2016).
At present, microcrystals for SX are mainly grown by batch
crystallization, as this often allows large amounts of well
ordered and homogeneously sized samples to be obtained.
This approach works well for many small and globular
proteins, such as hen egg-white lysozyme. Here, crystal sizes
can be well controlled by systematically changing the growth
parameters, such as precipitant concentration, pH value and
temperature (Falkner et al., 2005). For other proteins that
consist of more than one domain and therefore inherit a
certain flexibility, finding the right crystallization conditions is
much more challenging. High supersaturation levels often
result in protein precipitation. The right crystallization
conditions are often found using specially designed sparse-
matrix screens in combination with the vapor-diffusion
method, which can be automatically set up in 96-well sitting-
drop plates using crystallization robots. Compared with batch
crystallization, this allows a wider screening of the crystal-
lization space, since both the protein and precipitant concen-
trations change during equilibration. For such samples, batch
crystallization often does not work at all or the conditions
cannot be readily concluded from the initially determined
sitting-drop crystallization conditions (Chayen, 1998; Murray
et al., 2015; Wu et al., 2015). One possible approach to use
crystals grown by sitting-drop vapor diffusion for SX experi-
ments is to pool crystals from a large number of crystallization
drops. However, this procedure is very time-consuming,
induces further crystal-handling steps which can potentially
damage the crystals, and is inapplicable for larger crystals as
they can no longer be handled as crystal suspensions owing to
crystal sedimentation.
A very promising approach for static structure determina-
tions has been developed by Opara and coworkers, in which
protein crystals are grown by the vapor-diffusion technique
directly on an array of up to 196 silicon nitride membranes
on a silicon support structure (Opara et al., 2017). For data
collection these 196 compartments need to be sealed with a
second silicon nitride membrane, which is placed on top of the
silicon support structure, in order to prevent the crystals from
drying out. As a consequence, the crystals are not accessible to
any chemical reactant after sealing, preventing, for example,
micro-diffusion and other time-resolved experiments. A
similar approach for on-chip microbatch crystallization
between two micro-structured single-crystalline quartz plates
has recently been reported by Ren et al. (2018).
We have developed a sitting-drop ‘on-chip crystallization’
approach for fixed-target SX experiments at both synchro-
trons and XFELs, in which up to 100 000 crystals can be grown
on a single chip. The method is applicable to both batch
crystallization and sitting-drop vapor-diffusion experiments.
In contrast to other approaches, in which crystals are typically
surrounded by large amounts of mother liquor during data
collection, our approach allows the mother liquor to be very
efficiently removed through micro-pores in the chip substrate,
thus yielding ‘naked crystals’. By additionally avoiding any
sealing material, this results in much lower background scat-
tering levels and makes the crystals directly accessible to
ligand and substrate solutions for ligand-binding studies and
time-resolved micro-diffusion experiments. The crystal-
lization chips are furthermore compatible with the fast-
scanning Roadrunner goniometer, making the method
ideally suited to time-resolved experiments at XFELs
(Tolstikova et al., 2019).
In this manuscript, we describe the successful application of
this on-chip crystallization approach to six different model
proteins: lysozyme, proteinase K, thermolysin, thaumatin, a
carbon monoxide dehydrogenase and the human membrane
protein aquaporin 2. For three of these proteins, diffraction
data were collected. Measurements were performed at
synchrotron sources and at the XFEL Linac Coherent Light
Source (LCLS) in Stanford, USA. The suitability of our on-
chip crystallization system for on-chip ligand-binding studies is
demonstrated by the structure solution of two protein–ligand
complexes that are new to the Protein Data Bank: thermolysin
in complex with aspartate and the human kinase DRAK2 in
complex with Mg2+-ADP.
research papers
IUCrJ (2019). 6, 714–728 Julia Lieske et al.  On-chip crystallization and ligand binding 715
2. Materials and methods
2.1. Roadrunner silicon chips for SX experiments
For our experiments two different chip designs were used,
which are shown in Fig. 1. Both chip designs are based on the
principle described by Roedig et al. (2015, 2016). The chips are
manufactured from single-crystalline silicon and provide a
thin membrane area with a thickness of 10–20 mm equipped
with a periodic pattern of micro-pores holding the crystals.
The smaller Roadrunner I chips with a membrane area of 1.5
 1.5 mm2 are well suited for cryogenic and room-tempera-
ture data collection at synchrotrons and XFELs. They are
especially applicable if only limited amounts of sample are
available and the crystals typically do not grow too large, as 2–
3 ml of crystallization solution is sufficient to cover the entire
chip. Owing to their compact design they are further ideally
suited for ligand-binding studies and time-resolved experi-
ments at synchrotrons, as the chips are attached to standard
magnetic mounts, which are compatible with most MX
beamlines. The larger Roadrunner II chips, which are usually
loaded with 100 ml crystallization solution, are ideally suited
if large amounts of sample are available. Roadrunner II chips
have already been successfully employed for fast SX data
acquisition using the Roadrunner II setup at XFELs such as
the MFX and CXI beamlines at LCLS.
2.2. On-chip crystallization and data collection using
compact Roadrunner I chips
Protein crystallization by vapor diffusion requires a closed
environment for equilibration between the protein-containing
drop and a larger reservoir. As no commercially available
system met our needs, we designed chambers for on-chip
crystallization on both types of Roadrunner chips. For
Roadrunner I chips, a six-well crystallization chamber with
dimensions of 60 58 24 mm (width length height) was
designed and 3D-printed using polylactic acid as the substrate
material. In a typical on-chip sitting-drop crystallization
experiment, a 2–3 ml drop of protein–precipitant mixture is
pipetted and spread over the silicon chip and subsequently
equilibrated against a larger amount of precipitant solution
(500 ml). The six wells of a crystallization chamber are
independent; thus, six different conditions or protein samples
can be tested simultaneously. The procedure for a crystal-
lization experiment on Roadrunner I chips is illustrated and
described in detail in Fig. 2.
For feasibility studies, the two proteins proteinase K and
thermolysin were crystallized on Roadrunner I chips. Protei-
nase K crystals with dimensions of 20–30 mm were grown by
mixing 15 mg ml1 proteinase K (Tritirachium album, Carl
Roth) in 0.1M CHC buffer pH 7.0, 10 mM CaCl2 in a 1:1 ratio
with precipitant solution (0.1M CHC buffer pH 6.5, 0.6M
ammonium sulfate, 10 mM CaCl2). 3 ml of this mixture was
applied onto a Roadrunner I chip and 500 ml precipitant
solution was used as the reservoir. Crystals typically appeared
within 12–14 h at room temperature. For on-chip crystal-
lization of thermolysin (Geobacillus stearothermophilus,
Sigma), the protein was dissolved in 50 mM NaOH to a final
concentration of 20 mg ml1 and was mixed in a 1:1 ratio with
precipitant solution (0.1M MES–NaOH pH 6.5, 10 mM
CaCl2, 25% PEG 2000). 3 ml of this mixture was applied onto a
Roadrunner I chip and equilibrated against 500 ml precipitant
solution to obtain crystals of 35  140 mm in size after 1–2
days of incubation at room temperature. Crystal growth was
monitored using an Olympus SZX16 microscope, as well as an
associated camera and the Olympus cellSens Standard soft-
ware for crystal size measurements.
Data collection from thermolysin crystals grown on Road-
runner I chips was carried out at cryogenic temperatures on
beamline P11 at the PETRA III storage ring at DESY
(Burkhardt et al., 2016). After the removal of excess mother
liquor, the chips were flash-cooled in liquid nitrogen as illu-
strated in Figs. 2(e) and 2( f). After cooling, the chips were
kept at cryogenic temperature and mounted manually on the
goniometer for data collection. For room-temperature
measurements of on-chip-grown proteinase K, the mother
liquor was removed directly on the beamline and the crystals
were kept hydrated by placing the chip in a stream of humi-
dified air as described by Roedig et al. (2016). In both cases,
single crystals were manually centered and diffraction data
consisting of 30–60 rotation wedges for around 20–30 crystals
per chip were measured at
12 keV using a 20  20 mm
focused beam. Diffraction data
were individually processed with
XDS (Kabsch, 2010) and merged
using the unit-cell cluster analysis
in BLEND (Foadi et al., 2013),
which included the automatic
removal of data affected by
radiation damage. Structures
were solved by molecular repla-
cement with Phaser (McCoy et al.,
2007) using PDB entries 4b5l
(J. Jakoncic, V. Stojanoff & V.
Honkimaki, unpublished work)
and 2tlx (English et al., 1999) as
template structures for proteinase
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Figure 1
Chip designs for the on-chip crystallization of proteins. (a) Roadrunner I chips have overall dimensions of
4.5  2.5 mm and up to 10 000 micro-pores, and are equipped with a standard magnetic base, making them
compatible with data collection on most MX synchrotron beamlines. (b) Roadrunner II chips are much
larger, with overall dimensions of 32 12 mm, and provide up to 300 000 micro-pores for crystals. They are
glued onto an aluminium support frame (shown in light gray), which is mounted on a standard magnetic
mount (shown in black). Room-temperature data collection with Roadrunner II chips requires a special
scanning stage with a long travel range of more than 32 mm, such as the Roadrunner II goniometer
(Tolstikova et al., 2019). The so-called ‘humidor’ (shown in green) can be slid over the chip to protect the
crystals from drying out and from light exposure.
K and thermolysin, respectively. Manual model building and
structure refinement were performed in Coot (Emsley et al.,
2010) and PHENIX (Adams et al., 2010). Figures of structural
models and electron-density maps were prepared with
PyMOL (DeLano, 2002).
2.3. On-chip crystallization and data collection on
Roadrunner II chips
Prior to on-chip crystallization experiments, Roadrunner II
chips were glued onto an aluminium
support frame to facilitate chip hand-
ling. The chip carrying the crystals can
be protected using a so-called
‘humidor’. This is a small movable cover
that provides a humid environment for
the crystals in order to prevent them
from drying out during transport. The
assembly of a Roadrunner II chip
device and the working principle of the
humidor are illustrated in Fig. 3.
Following the same design as for
Roadrunner I chips, we designed a
crystallization chamber for Roadrunner
II chips. The chamber has dimensions of
40  46  21 mm (width  length 
height) and can accommodate one chip,
which is inserted through a lateral slit at
one side of the chamber. The chamber
can be filled with up to 10 ml reservoir
solution. The procedure for on-chip
crystallization on Roadrunner II chips is
illustrated in Fig. 4.
Human aquaporin 2 (hAQP2) was
heterologously expressed in Pichia
pastoris and purified via affinity and
size-exclusion chromatography as
described previously (Frick et al., 2014).
Purified protein solution in 20 mM Tris
pH 8.0, 0.3M NaCl, 0.2% octyl glucose
neopentyl glycol (OGNPG) was
concentrated to 9 mg ml1. The reser-
voir solution consisted of 0.1M Tris pH
8.5, 0.1M NaCl, 0.1M MgCl2, 22–25%
PEG 400. For on-chip crystallization,
the reservoir solution was diluted in a
4:1 ratio with 0.1M CdCl2. The resulting
solution was then thoroughly mixed in a
1:1 ratio with protein solution, homo-
genously applied to the chip and equi-
librated against a larger volume of
5–7 ml reservoir solution at room
temperature. Crystals grew within
15 min to a few hours.
Carbon monoxide dehydrogenase
(CODH) from Oligotropha carboxido-
vorans was isolated and purified as
described previously (Dobbek et al., 1999; Gremer et al., 2000).
5 ml reservoir solution composed of 0.75MKH2PO4/KOH pH
7.5, 0.75M NaH2PO4/NaOH pH 7.5, 94 mM HEPES/NaOH
pH 7.5, 3% MPD was used in the experiment. On-chip crys-
tallization was set up by mixing protein solution (19.3 mg ml1
in 50 mM HEPES pH 7.0) with reservoir solution containing
seeds in a 1:1 ratio. Seeds were obtained by crushing two
250 mm crystals that had previously been grown by conven-
tional hanging-drop crystallization using the same conditions
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Figure 2
Procedure for on-chip crystallization on Roadrunner I chips. (a) For a crystallization experiment,
the top of the chamber is sealed with transparent tape before the chamber wells are filled with
500 ml reservoir solution through the side opening. (b) The protein solution is mixed with
precipitant solution and about 2–3 ml of this crystallization mixture is applied to the chip surface. (c)
The chips are inserted into the crystallization chamber from the side and are held in place by a
magnetic ring attached to the lateral opening of the chamber that interacts with the magnetic base
of the chip. (d) Crystal-growth kinetics are monitored by light microscopy using top light
illumination. (e) When crystal growth is complete, the chips are taken out of the chamber using a
magnetic wand. The excess growth solution is removed through the membrane pores of the chip
using a soft tissue, as described by Roedig et al. (2015, 2016). During all handling steps, starting from
the removal of the mother liquor and until room-temperature measurements at the beamline are
finished, it is essential to keep the crystals hydrated in a stream of humidified air (Sanchez-
Weatherby et al., 2009; Roedig et al., 2016). The optimal level of applied humidity has to be tightly
controlled and investigated beforehand for each protein individually, as this depends on the buffer
composition (Wheeler et al., 2012). For protein buffers that only contain low concentrations of salt
and/or PEG, 98–100% humidity is usually suitable. ( f ) As an alternative to room-temperature
measurements, crystals on a chip can be flash-cooled by plunging the chip into liquid nitrogen prior
to cryogenic data collection (Roedig et al., 2015).
in 50 ml reservoir solution. Crystals grew on the chip at 4C
after approximately 2.5 days.
All other proteins crystallized on Roadrunner II chips were
purchased from commercial vendors. Their crystallization
conditions are summarized in Table 1.
Room-temperature data were collected from hAQP2 crys-
tals grown on Roadrunner II chips at the MFX experimental
station at LCLS using the Roadrunner II fast-scanning gonio-
meter (Tolstikova et al., 2019) in combination with the CSPAD
detector. The crystals were exposed to a constant stream of
humidified helium during data collection to prevent crystal
dehydration and to reduce background scattering by air. Data
were collected at 9.070 keV with an energy of 2 mJ per 60 fs
X-ray pulse and a focal spot size of 1 mm2.
After manual alignment, the chips were raster-scanned at a
rate of 120 images per second, using a step size of 50 mm and a
tilt angle of 25 between the chip-surface normal and the
incident X-ray beam in order to avoid incomplete data owing
to preferred orientation of the crystals on the chip. One scan
of an entire chip took about 15–20 min including chip align-
ment. We usedOnDa (Mariani et al., 2016) to monitor the data
collection, Cheetah (Barty et al., 2014) for hit finding and data
reduction, Merge3D to check the orientation bias (Yefanov et
al., 2014) and CrystFEL (White et al., 2012, 2016) for indexing
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Table 1
Size comparison of crystals grown via conventional hanging-drop experiments versus crystals grown on Roadrunner II chips using the same
crystallization condition.
In all cases protein solutions were mixed with precipitant solutions in a 1:1 ratio. The volumes used for the drop and the reservoir were 6 and 500 ml for the hanging-
drop experiments and 100 ml and 5–7 ml for the on-chip crystallization experiments, respectively. Unless otherwise stated, crystallization experiments were
performed at room temperature.
Sample Crystallization condition Hanging-drop crystals On-chip crystals
hAQP2 (Homo sapiens) 9 mg ml1 protein, 0.1M Tris pH 8.5, 0.1M NaCl,
0.1M MgCl2, 10 mM CdCl2, 22–25% PEG 400
Different shapes and sizes,
ranging from small needles
to blocky rods
Different shapes and sizes, ranging
from small 10 mm needles to
larger 20  250 mm needles
and up to 50  150 mm blocky rods
CODH (Oligotropha
carboxidovorans)
19.3 mg ml1 protein, 0.75M KH2PO4/KOH
pH 7.5, 0.75M NaH2PO4/NaOH pH 7.5, 94 mM
HEPES/NaOH pH 7.5, 3% MPD at 4C
50–100 mm wide, blocky,
rod-shaped
50–100 mm wide, blocky, rod-shaped
Lysozyme (Gallus gallus) 80 mg ml1 protein, 0.1M sodium acetate pH 4.8,
12% NaCl, 20% ethylene glycol
50–170 mm, cuboid Up to 170 mm, cuboid
Lysozyme (Gallus gallus) 60 mg ml1 protein, 50 mM sodium acetate pH 3.5,
0.75M NaCl, 30% ethylene glycol, 11.25% PEG
400 at 4C
Up to 180 mm, cuboid Up to 170 mm, cuboid
Proteinase K (Tritirachium
album)
20 mg ml1 protein, 0.1M CHC buffer pH 6.5,
10 mM CaCl2, 0.7M ammonium sulfate
40–50 mm, rhomboid Up to 80–125 mm, rhomboid
Thaumatin (Thaumatococcus
daniellii)
10 mg ml1 protein, 0.1M ADA pH 6.5,
0.9M sodium/potassium tartrate
Up to 140 mm, rhomboid Up to 120 mm, rhomboid
Thermolysin (Geobacillus
stearothermophilus)
22.5 mg ml1 protein, 0.1M MES–NaOH pH 6.5,
10 mM CaCl2, 5% PEG 2000
Up to 60  300 mm, rod-shaped Up to 60  320 mm, rod-shaped
Figure 3
Roadrunner II chip design. (a) For assembly, a magnetic base (Thorlabs) is screwed to an aluminium support frame and a Roadrunner II chip is glued on
top of the frame cavity. Both assembly steps are assisted by special tools to guarantee perpendicular installation of the base with respect to the support
frame and a defined and reproducible position of the chip. The humidor (green) is equipped with a dry piece of tissue and can be slid to the base of the
aluminium support frame. (b) The humidor was designed to keep naked crystals on the chip in a humid environment. For the short transport between the
crystal-preparation laboratory and the beamline, the tissue in the humidor is soaked with water or mother liquor through the gaps on top and the
humidor is slid over the chip.
and merging. The hAQP2 structure PDB entry 4nef (Frick et
al., 2014) served as a model template for structure solution
with Phaser. The structural model was built and refined in
Coot and PHENIX, respectively (Emsley et al., 2010; Adams et
al., 2010).
2.4. On-chip ligand-binding studies
Our crystallization chambers constitute a valuable tool for
ligand-soaking experiments, as they provide a stable envir-
onment even for extended incubation times of several days to
weeks. The procedure for a ligand-soaking experiment on a
Roadrunner I chip is illustrated in Fig. 5. Our setup is not
limited to on-chip-grown crystals, but can also be used for
protein crystals grown in batch.
We studied the complexes of on-chip crystallized thermo-
lysin with aspartate and in-batch crystallized human serine/
threonine kinase 17B (also known as DRAK2) in complex
with its natural ligand ATP via on-chip ligand soaking.
Human DRAK2 was expressed and purified in-house
following the protocols described on the web pages of the
Structural Genomics Consortium (http://www.thesgc.org). In
brief, N-terminally His-tagged DRAK2 was expressed in
Escherichia coli. After cell lysis by ultrasound sonification and
centrifugation, the DRAK2 protein in the supernatant was
purified via nickel-affinity chromatography and subsequent
gel filtration using a Superdex S200 HiLoad column. Fractions
containing the DRAK2 protein were
pooled and concentrated to
20 mg ml1. The final buffer (25 mM
HEPES pH 7.5, 500 mM NaCl, 0.5 mM
TCEP) was compatible with flash-
cooling of the protein and storage at
80C. Batch crystallization of DRAK2
was performed by mixing 20 mg ml1
thawed protein in a 1:1.5 ratio with
0.2M ammonium acetate, 20% PEG
3350, 50 mM sodium/potassium tartrate,
0.8 mM quercetin. Crystals of 30–40 mm
were ready for experiments after one
day of incubation at 20C.
We soaked thermolysin and DRAK2
crystals for minutes to hours on Road-
runner I chips. We used 200 mM sodium
aspartate (in 0.1MMES–NaOH pH 6.5,
10 mM CaCl2, 25% PEG 2000, 25%
ethylene glycol) and 50 mM ATP (in
0.2M ammonium acetate, 20% PEG
3350, 50 mM sodium/potassium tartrate,
25% ethylene glycol) for thermolysin
and DRAK2, respectively.
Diffraction data collection at cryo-
genic temperatures, data processing and
structure refinement was performed as
described for the Roadrunner I chips
(see above). Structures were solved by
molecular replacement with Phaser
(McCoy et al., 2007) using PDB entries
2tlx (English et al., 1999) and 3lm5
(Structural Genomics Consortium,
unpublished work) as the template
structures for thermolysin and DRAK2,
respectively.
3. Results
3.1. Roadrunner I chips
In a conventional hanging-drop
vapor-diffusion experiment, proteinase
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Figure 4
Procedure for on-chip crystallization using Roadrunner II chips. (a) The top opening of the
crystallization chamber is sealed with transparent sticky tape and the chamber is subsequently filled
with 5–10 ml reservoir solution through the side opening. (b) 100 ml of the protein–precipitant
mixture is applied to the chip and carefully spread over the whole chip area using a pipette tip or a
rectangular cover slide. (c) The chip holder is then inserted through the side opening of the chamber
and the remaining cleft between the chamber and chip holder is sealed with Parafilm to minimize
evaporation. (d) In the sealed chamber, the vapor-diffusion process leads to a decrease in the drop
volume. (e) Crystal growth on the chip can be monitored by light microscopy using top light
illumination. ( f ) After crystal growth has finished, the chip is removed from the crystallization
chamber. Under a stream of humidified air, as shown here in a so-called ‘chip-loading station’, the
mother liquor is carefully and thoroughly removed through the pores of the chip with a soft tissue.
This handling step can be observed through the transparent window on top of the loading station.
Afterwards, the humidor is slid over the chip and the naked crystals can be safely transported to the
beamline for data collection.
K crystals of 30 mm appeared overnight at room tempera-
ture when 6 ml of a 1:1 mixture of 15 mg ml1 protein solution
and precipitant solution consisting of 0.6M ammonium sulfate
was equilibrated against 500 ml reservoir solution. Using the
same crystallization conditions (3 ml of a 1:1 mixture
containing 15 mg ml1 proteinase K equilibrated against
500 ml reservoir solution), we crystallized proteinase K on
Roadrunner I chips, resulting in 25–
40 mm crystals overnight [Fig. 6(b)]. The
crystals were evenly distributed over
the whole chip area and remained in
place when the mother liquor was
removed. We obtained the same result
for the crystallization of thermolysin.
Using identical crystallization condi-
tions for both conventional hanging-
drop experiments and crystallization on
Roadrunner I chips, thermolysin crys-
tals were observed to grow reproducibly
to a maximal size of around 35 
150 mm.
Diffraction data from proteinase K
and thermolysin crystals were collected
on beamline P11 of the PETRA III
storage ring (Burkhardt et al., 2016)
using the abovementioned multi-crystal
approach at room temperature and
cryogenic temperature, respectively
(Table 2).
We solved the room-temperature
proteinase K structure at 1.74 A˚ reso-
lution [Fig. 7(a)] using diffraction data
from three 30 mm crystals merged
according to BLEND cluster analysis
and using PDB entry 4b5l as the
template for molecular replacement. Comparison with either
PDB entry 5avj (Yazawa et al., 2016), a cryogenic temperature
structure of proteinase K at 1.45 A˚ resolution, or PDB entry
1ic6 (Betzel et al., 2001), a 0.98 A˚ resolution room-tempera-
ture structure of proteinase K, reveals that our structure is
identical to the available structures in the PDB (main-chain
r.m.s.d.s of 0.210 and 0.230 A˚, respectively), only showing the
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Figure 5
Procedure for on-chip ligand-soaking experiments. (a) Crystals are either grown on Roadrunner I
chips or 1–3 ml of batch-grown crystals are applied to the chip. Under a stream of humidified air, the
mother liquor is removed from the chip through the pores. (b) 2–3 ml of ligand-soaking solution is
applied to the crystals. (c) One well of the crystallization chamber is filled with the appropriate
reservoir solution. The chip is installed in the crystallization chamber and incubated for the desired
time period. (d) The soaking solution is removed through the pores of the chip and crystals are
either measured at room temperature or the chip is cooled in liquid nitrogen for cryogenic data
collection.
Table 2
Diffraction and refinement data statistics for proteins crystallized and soaked on Roadrunner I chips.
Proteinase K Thermolysin Thermolysin–aspartate DRAK2–ADP
PDB code 6qf1 6qf2 6qf3 6qf4
Data-collection temperature (K) 298 100 100 100
No. of crystals merged 3 3 5 4
Space group P43212 P6122 P6122 P4122
a, b, c (A˚) 68.47, 68.47, 108.27 92.67, 92.67, 128.31 93.15, 93.15, 129.29 85.48, 85.48, 118.07
, ,  () 90, 90, 90 90, 90, 120 90, 90, 120 90, 90, 90
Resolution range (A˚) 44.20–1.74 (1.77–1.74) 46.33–1.73 (1.77–1.73) 46.58–1.52 (1.55–1.52) 42.74–2.50 (2.60–2.50)
Rmeas 0.150 (0.677) 0.175 (1.013) 0.121 (0.932) 0.113 (0.522)
Mean I/(I) 10.9 (3.4) 11.4 (3.1) 21.6 (4.7) 14.7 (5.3)
Completeness (%) 99.6 (99.9) 100 (100) 100 (99.6) 98.6 (99.0)
No. of unique reflections 27136 (1465) 34527 (1852) 51432 (2484) 15529 (1743)
Multiplicity 11.1 (11.3) 13.2 (13.6) 29.1 (29.2) 9.3 (9.7)
CC1/2 0.997 (0.921) 0.995 (0.810) 0.999 (0.939) 0.997 (0.992)
Mosaicity () 0.040 0.200 0.150 0.210
Wilson B factor (A˚2) 13.37 12.63 11.90 40.22
Resolution for refinement 44.20–1.74 (1.78–1.74) 46.33–1.73 (1.79–1.73) 46.58–1.52 (1.56–1.52) 42.74–2.50 (2.58–2.50)
No. of reflections used 27060 (1765) 34457 (2936) 51351 (3451) 15521 (1256)
No. of reflections used for Rfree 1995 (140) 1571 (139) 1939 (135) 1552 (139)
Rwork/Rfree 0.134/0.156 (0.185/0.214) 0.128/0.161 (0.165/0.204) 0.123/0.150 (0.152/0.178) 0.183/0.227 (0.239/0.259)
R.m.s.d., bond lengths (A˚) 0.005 0.006 0.010 0.002
R.m.s.d., bond angles () 0.746 0.841 1.162 0.476
Mean B factor (A˚2) 17.61 16.57 16.06 57.04
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Figure 7
Exemplary 2mFoDFc electron densities at 1.5 for the structures of proteinase K (a) and thermolysin (b) derived from crystals grown on Roadrunner I
chips. The Ca2+-binding site of proteinase K and the active site of thermolysin with two bound Zn2+ ions (gray spheres) are shown. Residues that are
involved in ion binding and/or are functionally important are represented as sticks and labeled. For a more detailed discussion on the thermolysin
structure, please see the supporting information.
Figure 6
Exemplary results of crystallization experiments for proteinase K (a, b) and thermolysin (c, d) using the same crystallization conditions for conventional
hanging-drop crystallization (a, c) and on-chip crystallization on Roadrunner I chips (b, d). The proteinase K crystals are around 30 mm in size and
appeared overnight. The thermolysin crystals needed 1–2 days to reach a maximal size of35 150 mm. The scale bars at the bottom right corners each
have a length of 200 mm. The different background colors in the pictures showing on-chip crystallization stem from the different polylactic acid colors
used for 3D-printing of the crystallization chambers.
conformational flexibility of side chains that is typical of room-
temperature structures.
For the apo form of thermolysin measured at cryogenic
temperature, structure solution and refinement was performed
with data merged from three individual crystals using the
native thermolysin structure with PDB code 2tlx (English et
al., 1999) as a template for molecular replacement. Our 1.73 A˚
resolution thermolysin structure superposes well with the
reference structure 2tlx, with an r.m.s.d. of 0.273 A˚ for all
main-chain atoms. A more detailed discussion of our ther-
molysin structure can be found in the supporting information.
3.2. Roadrunner II chips
We crystallized six different proteins on Roadrunner II
chips, including globular proteins such as proteinase K, hen
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Figure 8
Exemplary images of crystals grown in hanging drops (a, c, e) and on Roadrunner II chips (b, d, e) using the same crystallization conditions. The
crystallization conditions and crystal sizes for lysozyme (a, b), proteinase K (c, d) and thermolysin (e, f ) are summarized in Table 1.
egg-white lysozyme, thaumatin, thermolysin and carbon
monoxide dehydrogenase (CODH) as well as the human
membrane protein aquaporin 2 (hAQP2). Starting from
the optimized hanging-drop crystallization conditions, we
obtained crystals that already showed a similar size and shape
in the first attempt for all samples. The crystallization condi-
tions as well as the resulting crystal sizes are summarized in
Table 1. In general, the crystal growth and appearance showed
the same characteristics as in a conventional vapor-diffusion
experiment (Fig. 8). Protein crystals that exhibited a large
diversity in shape and size under a specific crystallization
condition, such as thaumatin and hAQP2, also appeared with a
similar shape and size distribution on the chips. For almost all
samples, crystals grew at a similar speed as in a conventional
sitting-drop experiment, ranging from 15 min to one day. Only
the growth of CODH crystals on the chip took approximately
2.5 days at 4C, in contrast to overnight growth in hanging
drops.
We collected serial diffraction data for on-chip crystallized
human aquaporin 2 (hAQP2) at room temperature at LCLS
using the fast-scanning Roadrunner II goniometer. From two
Roadrunner II chips we obtained 3377 hits from 137 476
collected frames (a 2.5% hit rate), leading to 2723 indexed
patterns (an 80.6% indexing rate). The measurement time per
chip was about 20 min for the first chip and about 9 min for the
second chip, resulting in a total measurement time of around
30 min for the full data set. The rod-shaped hAQP2 crystals
showed a strong preference for two distinct orientations
rotated along their long fourfold symmetry axis when lying on
the flat silicon-chip surface. The corresponding diffraction
patterns collected with a beam perpendicular to the chip plane
hence show a strong bias and Bragg peaks only cover a very
narrow region of reciprocal space (Fig. 9). In order to obtain a
complete data set, we tilted the chip by 25 during SX data
collection.
Using these data, the hAQP2 crystal structure was solved to
a resolution of 3.7 A˚ (Table 3), exhibiting lower overall quality
than the cryo-structure reported in the PDB with a resolution
of 2.75 A˚ (PDB entry 4nef; Frick et al., 2014). In order to
exclude any potential negative effect of our on-chip crystal-
lization on the crystal quality, we also measured hAQP2
crystals pooled from sitting-drop plates grown using the same
crystallization protocol. These crystals showed the same
diffraction properties and quality as the on-chip grown crys-
tals. From previous screening of cryo-cooled hAQP2 crystals
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Figure 9
Accumulated Bragg spots of 3000 patterns collected from hAQP2 crystals with the silicon chip oriented perpendicular to the beam (a) and at a tilt angle
of 25 (b). The preferred orientation of the crystals lying on the silicon-chip surface leads to poor coverage of reciprocal space. In order to obtain a more
complete data set, the chip has to be tilted during data collection. The color code of the scale bars indicates the number of patterns that contribute to
each pixel in merged reciprocal space.
Table 3
Data-collection and refinement statistics for human aquaporin 2 crystal-
lized on Roadrunner II chips.
PDB code 6qf5
Data-collection temperature (K) 298
No. of hits 3377
Indexed patterns 2903
Space group P42
a, b, c (A˚) 122.2, 122.2, 94.14
, ,  () 90, 90, 90
Resolution range (A˚) 37.38–3.70 (3.76–3.70)
Rsplit 0.437 (1.538)
Mean I/(I ) 2.32 (0.92)
Completeness (%) 99.97 (99.93)
No. of unique reflections 14866 (1462)
Multiplicity 28.1 (17.7)
CC* 0.937 (0.435)
Wilson B factor (A˚2) 93.37
Resolution for refinement 33.89–3.70 (3.82–3.70)
No. of reflections used 14805 (1110)
No. of reflections used for Rfree 1488 (127)
Rwork/Rfree 0.282/0.336 (0.398/0.419)
R.m.s.d., bond lengths (A˚) 0.004
R.m.s.d., bond angles () 0.761
Mean B factor (A˚2) 105.45
we have found a correlation between crystal size and
diffraction properties. Therefore, the weaker diffraction
properties of the crystals used in this work are most likely to
be owing to their significantly smaller size compared with the
crystals used for previous structural determination and do not
originate from our on-chip crystallization method.
Human AQP2 forms a homotetramer in the protein crystal
as well as in the biologically active structure (Fig. 10). Each
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Figure 10
Structure of human aquaporin 2 (hAQP2) obtained by room-temperature SFX from crystals directly grown on Roadrunner II chips. Views are parallel to
the membrane plane (a) and perpendicular to the membrane plane (b) in cartoon representation. hAQP2 forms a homotetramer, with each monomer
consisting of six transmembrane helices and two half-helices forming a pseudo-transmembrane helix. Each monomer is shown in a different color for
clarity. Gray lines indicate the unit cell axes. (c) Awater molecule (red sphere) is situated in the middle of the water channel of one monomer. The shown
surface represents the solvent-excluded surface area viewed from the extracellular side. (d) The view perpendicular to the water channel shows that the
water molecule is situated at a hydrogen-bond distance from the side chain of Asn68. This residue is part of the highly conserved dual NPA motif (pink
and cyan) in the center of aquaporin channels that plays a central role in channel selectivity. The 2mFo  DFc electron density is shown at 0.8.
monomer contains a water channel surrounded by six trans-
membrane helices and two half-helices forming a pseudo-
transmembrane helix. Comparison of our on-chip crystal
structure with the reference structure available in the PDB
(PDB entry 4nef), which was solved by conventional cryo-
crystallography, revealed no major differences in the overall
conformation of the tetramer. In particular, the predominantly
-helical and well ordered protein cores of both structures,
built by the 4  6 transmembrane helices, superimpose well
(r.m.s.d. of 0.622 A˚ for 1936 main-chain atoms), whereas the
surface loops naturally show higher flexibility. In general the
structures are similar, with an overall r.m.s.d. value of 0.928 A˚
for all 3596 main-chain atoms. Both of the Cd2+-binding sites
present in the reference structure PDB entry 4nef were
confirmed by our structure. Despite the limited resolution of
the data, clear density for a water molecule is observed in the
middle of the water-conducting pore of one of the hAQP2
monomers, close to the conserved NPA region. Further details
are provided in the supporting information.
3.3. On-chip ligand-binding studies
Our experiments revealed that our on-chip crystallization
chambers are very well suited for on-chip ligand-binding
experiments. A great advantage is the direct accessibility of
the ligand solution to the ‘naked’ crystals on the silicon chips.
Following this approach, we were able to solve the crystal
structures of on-chip crystallized thermolysin in complex with
aspartic acid and in-batch crystallized DRAK2 crystals in
complex with ADP, both of which are new structures to the
PDB.
Apo crystals of thermolysin were grown directly on Road-
runner I chips and were subsequently soaked with 200 mM
aspartate dissolved in mother liquor, using our on-chip crys-
tallization chambers in both steps. Diffraction data were
measured at cryogenic temperature. Structure solution and
refinement was performed using a 1.52 A˚ resolution data set
obtained by merging data from five crystals, using the native
thermolysin structure (PDB entry 2tlx; English et al., 1999) as
a template for molecular replacement. At the active site we
observed two bound aspartate molecules, one of which is
involved in the pentacoordination of the catalytic zinc ion
[Fig. 11(a)]. The binding mode of this aspartate molecule is
similar to that of asparagine bound to thermolysin (PDB entry
4m65; Yin et al., 2014). Details are provided in the supporting
information.
DRAK2 is a serine/threonine kinase that is involved in
autoimmune diseases and cancer (Sanjo et al., 1998; Doherty et
al., 2009; Yang et al., 2012; Edwards et al., 2015; Harris &
McGargill, 2015). DRAK2 crystals were grown by batch
crystallization and were soaked on a Roadrunner I chip for 1 h
with the natural ligand ATP using the on-chip crystallization
chamber. Cluster analysis of the collected data with BLEND
led to a 2.5 A˚ resolution data set merged from four individual
crystals. The crystal structure was solved via molecular
replacement using the quercetin-bound structure of DRAK2
(PDB entry 3lm5) as a search model. At the active site, elec-
tron density for the nucleotide and one coordinated magne-
sium ion is clearly visible, although the lack of density for the
-phosphate indicates that ATP was hydrolyzed to ADP
during incubation [Fig. 11(b)]. A more detailed description of
the active site and a comparison with structures of the related
kinase DAPK1 are provided in the supporting information.
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Figure 11
Ligand-binding sites of the structures obtained from on-chip ligand-soaking experiments using our crystallization chambers and Roadrunner I chips. (a)
An aspartate molecule (pink) in complex with a sodium ion (purple sphere) is bound to the active site of thermolysin. It is involved in the fivefold
coordination of the catalytic zinc ion (gray sphere) with both its amino and carboxy moieties. The 2mFo  DFc electron-density map at 1 is shown as a
blue mesh and catalytically important thermolysin residues (green) are labeled. (b) The 2mFo  DFc electron-density map at 1.5 clearly indicates the
presence of Mg2+-ADP (yellow sphere and pink sticks) at the active site of DRAK2.
4. Conclusion and outlook
4.1. On-chip crystallization
The recent evolution of high-intensity X-ray techniques
such as serial femtosecond crystallography (SFX) at XFELs
goes hand in hand with the need for extremely fast sample
exchange. Fixed-target sample holders are often advantageous
over liquid-jet and LCP systems, as they typically lead to much
higher hit fractions, provide lower background levels and work
more reliably, hence causing significantly reduced downtimes
of the instrument. Probably the most important advantage is
that they require orders of magnitude less sample.
Here, we present a new method for in-situ protein crystal-
lization directly on silicon chips, which provides a straight-
forward and highly reliable method for sample delivery for SX
experiments at synchrotrons and XFEL facilities. It constitutes
an alternative approach to batch crystallization, which, owing
to the harsh conditions, is not always possible for all proteins.
It also avoids time-consuming crystal pooling from tens to
hundreds of individual crystallization drops. Known hanging-
drop or sitting-drop crystallization conditions can be directly
transferred to the on-chip crystallization method and in most
cases do not require any further optimization.
Loading of pre-grown protein crystals onto fixed-target
sample holders in an efficient way has still remained challen-
ging, as this involves additional crystal-handling steps and
often leads to crystal clustering when the surrounding liquid is
removed (Soares et al., 2014). The on-chip crystallization
method is of particular interest for soft and fragile protein
crystals. These often suffer from shearing forces during
pipetting, which is now avoided since they are measured in situ
on their crystallization substrate. In general, we even expect a
higher crystal quality for the on-chip grown crystals owing to
the reduced crystal-handling steps. In addition, the on-chip
grown crystals remain in place upon the removal of the mother
liquor, showing no clustering. Hence, we achieve a more
homogenous distribution of the crystals on the chip for SX
measurements, preventing multiple crystals per exposure.
The hit rates of 2.5% as observed for hAQP2 on the
Roadrunner II chips were low for a fixed-target experiment
and can probably be attributed to the low protein concen-
tration that was used. The number of crystals on the chip could
be increased by using a larger amount of crystallization solu-
tion, as Roadrunner II chips have a high capacity of at least
120 ml of solution. An alternative approach for increasing the
crystal density is to vary the crystallization parameters such as
the protein and precipitant concentration. This strategy was
not applicable for hAQP2 as it causes unwanted changes in the
crystal morphology. However, even though the hit rates were
low, a total data collection of 30 min still appears to be
reasonable for an SFX structure determination.
4.2. On-chip ligand binding
X-ray crystallography allows the study of the interaction of
pharmaceutical target proteins with potential drugs on the
atomic level, which often requires the screening of hundreds
to thousands of different compounds. To date, most of these
ligand-binding experiments have been performed manually
using conventional crystallography. For these studies, rela-
tively large crystals are individually harvested from their
growth solution, transferred to the solution containing the
ligand and subsequently flash-cooled for cryogenic data
collection (Schiebel et al., 2016). These steps have to be
repeated for every ligand solution. Consequently, these studies
are a very tedious and time-consuming procedure. Even
though efforts have been undertaken to automate the crystal-
harvesting step (Deller & Rupp, 2014; Samara et al., 2018), the
whole procedure remains a major bottleneck for screening of
entire chemical libraries. Here, we show that fixed-target serial
crystallography provides a very promising alternative to these
conventional ligand-binding studies. In contrast to current
practice, our method avoids most of the crystal-handling steps
as the crystals are grown and soaked with the ligand solution
directly on their support structure and measured in situ.
The Roadrunner crystallization chambers provide a well
suited environment for ligand-binding experiments, as we
show for the binding of aspartate to thermolysin and for the
DRAK2–ADP complex. In difficult cases, where the desired
compound is sparsely soluble, our system has the advantage
that the mother liquor can be completely removed prior to
application of the ligand solution. Hence, the ‘naked’ crystals
can be exposed to the highest possible ligand concentrations.
Furthermore, Roadrunner I chips are compatible with data
collection at most synchrotron MX beamlines, as the chips are
mounted on commonly used standard magnetic bases. In
combination with sample-changing robots and automated
raster-scanning procedures of the chips, which are increasingly
available at synchrotron beamlines such as DESY beamline
P11 (Burkhardt et al., 2016), this should allow much faster and
more efficient ligand-binding studies at synchrotron sources.
The use of polychromatic ‘pink’ X-ray beams providing much
higher X-ray intensities should make data collection even
faster. The larger bandwidth of up to 5% for a polychromatic
X-ray beam has been shown to further significantly reduce the
number of crystals and thus the amount of sample required to
obtain a complete data set. In a recent pink-beam diffraction
experiment, still diffraction images collected from only 50
microcrystals were sufficient for protein structure determina-
tion (Meents et al., 2017). Hence, the combination of pink-
beam SX, on-chip crystallization and on-chip ligand-binding
experiments holds huge potential for high-throughput ligand
screening of pharmaceutically relevant target proteins.
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